# Betula pubescens

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/betula-pubescens
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** European
**Also Known As:** downy birch, white birch, pubescent birch, European white birch, hairy birch, moorland birch, Betula alba, Betula odorata

## Overview

Betula pubescens (white birch) contains bioactive triterpenoids such as betulin and betulinic acid, which are the primary compounds driving its studied pharmacological effects. These compounds interact with apoptotic pathways and immune-regulatory mechanisms, making white birch a subject of early-stage oncological and immunological research.

## Health Benefits

• May reduce cancer cell viability in digestive cancers through apoptosis induction (preliminary in vitro evidence, PMID: 34755444)
• Potential [immunomodulatory](/ingredients/condition/immune-support) effects via dendritic cell regulation (preliminary in vitro evidence, PMID: 21237202)
• May shift immune responses from inflammatory Th1 to regulatory Th17 phenotypes (preliminary in vitro evidence)
• Traditional use for skin disorders and rheumatism (historical evidence only)
• Potential [anti-inflammatory](/ingredients/condition/inflammation) properties through cytokine modulation (preliminary in vitro evidence)

## Mechanism of Action

Betulinic acid, a primary triterpenoid in Betula pubescens, induces apoptosis in cancer cells by activating the [mitochondrial](/ingredients/condition/energy) (intrinsic) pathway, triggering cytochrome c release and caspase-3/9 activation while downregulating anti-apoptotic Bcl-2 proteins. Extracts also modulate dendritic cell maturation by influencing toll-like receptor signaling and cytokine secretion profiles, notably shifting the T-helper cell balance away from pro-[inflammatory](/ingredients/condition/inflammation) Th1 responses toward regulatory or Th2-skewed phenotypes. Betulin additionally inhibits NF-κB transcription factor activity, reducing downstream inflammatory mediator production including TNF-α and IL-6.

## Clinical Summary

Current evidence for Betula pubescens is limited almost entirely to in vitro (cell culture) studies, with no large-scale human clinical trials published to date. One in vitro study (PMID: 34755444) demonstrated that Betula pubescens extracts reduced viability of digestive cancer cell lines through apoptosis induction, though the concentrations used may not be directly translatable to human dosing. [Immunomodulatory](/ingredients/condition/immune-support) effects on dendritic cells were observed in another in vitro model (PMID: 21237202), suggesting potential Th1-to-Th2 immune shifting, but without animal or human confirmation these findings remain preliminary. The overall evidence base is insufficient to support therapeutic claims, and controlled clinical trials are needed before efficacy conclusions can be drawn.

## Nutritional Profile

Betula pubescens (downy birch) contains bioactive compounds primarily concentrated in bark, leaves, and sap rather than conventional macronutrients. Key documented compounds include: Betulin (lupane-type triterpene, ~70-80% of dry bark extract weight in outer bark), Betulinic acid (typically 0.1-0.5% of dry bark weight, derived from betulin oxidation), and Lupeol (minor triterpene constituent). Leaves contain flavonoids including hyperoside (quercetin-3-galactoside, ~0.5-1.2% dry weight), myricetin glycosides, and quercetin derivatives. Birch sap (collected in early spring) provides fructose and glucose (~0.5-2% total sugars), small amounts of amino acids (glutamine, alanine, serine), malic acid, and trace minerals including potassium (~100-150 mg/L), calcium (~10-30 mg/L), magnesium (~5-15 mg/L), and manganese. Tannins (predominantly condensed catechins) are present in bark at ~2-5% dry weight. Volatile essential oils in buds and leaves include methyl salicylate, betulenol, and alpha/beta-pinene at trace levels (<1%). Chlorogenic acid and caffeic acid derivatives are present in leaf material (~0.3-0.8% dry weight). Bioavailability note: Betulin shows poor oral bioavailability due to high lipophilicity (log P ~7.5); nanoformulation or esterification (e.g., betulinic acid form) substantially improves absorption. Flavonoids from leaf preparations show moderate bioavailability enhanced by gut microbiota deglycosylation. Sap-derived minerals are in bioavailable ionic form. Conventional macronutrient data (protein, fat, carbohydrate as food values) is not applicable given non-food/medicinal use context; no established RDI contributions documented.

## Dosage & Preparation

No clinically studied dosage ranges are available from human trials. In vitro studies used unspecified concentrations of bud flavonoids and ethanol bark extracts without standardization details or human dosing information. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Betula pubescens is generally considered low-risk when used in traditional contexts such as birch leaf teas, but formal safety profiling via controlled human trials is lacking. Individuals with known birch pollen allergies (a common aeroallergen) should exercise caution, as cross-reactive allergens in the plant may trigger oral allergy syndrome or systemic hypersensitivity reactions. Potential interactions with immunosuppressant drugs (e.g., cyclosporine, tacrolimus) are theoretically plausible given the documented [immunomodulatory](/ingredients/condition/immune-support) activity, though no clinical interaction data exist. Pregnant and breastfeeding women should avoid concentrated extracts or supplements due to the complete absence of reproductive safety data.

## Scientific Research

Current evidence for Betula pubescens is limited to in vitro studies with no human clinical trials, RCTs, or meta-analyses available. Key studies include PMID: 34755444 showing bud flavonoids induced apoptosis in gastric, colon, and liver cancer cell lines, and PMID: 21237202 demonstrating bark extract modulation of dendritic cell maturation and [cytokine](/ingredients/condition/inflammation) secretion.

## Historical & Cultural Context

Birch bark extracts from Betula pubescens have been traditionally used in European folk medicine for treating skin disorders, rheumatism, and as an analgesic remedy. The immunoregulatory effects noted historically align with modern in vitro findings on immune cell modulation.

## Synergistic Combinations

Willow bark, Turmeric, Green tea extract, Echinacea, Reishi mushroom

## Frequently Asked Questions

### What is betulinic acid and why is it important in Betula pubescens?

Betulinic acid is a pentacyclic lupane-type triterpenoid found in the bark of Betula pubescens and is considered its most pharmacologically significant compound. It selectively induces apoptosis in cancer cells by activating the intrinsic mitochondrial pathway, involving caspase-3 and caspase-9 activation and Bcl-2 downregulation, without comparable toxicity observed in normal cells in vitro.

### Does Betula pubescens have anti-cancer properties?

Preliminary in vitro evidence (PMID: 34755444) indicates that Betula pubescens extracts can reduce the viability of digestive cancer cell lines by inducing apoptosis, primarily attributed to betulinic acid. However, these findings are from cell culture experiments only, and no human clinical trials have confirmed anti-cancer efficacy, so it cannot be recommended as a cancer treatment.

### How does Betula pubescens affect the immune system?

In vitro research (PMID: 21237202) suggests that Betula pubescens extracts modulate dendritic cell activity, influencing how these antigen-presenting cells direct T-helper cell differentiation. Specifically, the extracts appear to shift immune responses away from pro-inflammatory Th1 cytokine profiles (associated with TNF-α and IFN-γ) toward a Th2 or more regulatory phenotype, though this has not been confirmed in human studies.

### Is Betula pubescens safe for people with birch pollen allergies?

Betula pubescens belongs to the same genus responsible for birch pollen, one of the most prevalent aeroallergens in temperate climates. People with documented birch pollen allergy may experience oral allergy syndrome or allergic reactions when consuming birch-derived preparations, as cross-reactive proteins such as Bet v 1 homologs can be present in plant tissues. Allergy testing and consultation with a physician are advisable before use.

### What is the typical dosage of Betula pubescens extract used in research?

No standardized human dosage for Betula pubescens extract has been established, as published studies are confined to in vitro models where concentrations are expressed in micrograms per milliliter (µg/mL) and are not directly translatable to oral human doses. Traditional European herbal use of birch leaf preparations typically involves 2–3 grams of dried leaf as a tea, but this form and concentration differ significantly from the concentrated extracts tested in laboratory settings.

### What is the difference between Betula pubescens and other birch species used in supplements?

Betula pubescens (downy birch) differs from Betula pendula (silver birch) primarily in its habitat preference and chemical composition, with pubescens containing higher concentrations of certain triterpenes and phenolic compounds. While both species are used traditionally and in research, pubescens has shown specific immunomodulatory effects in preliminary studies that may not be equivalent across species. The WHO/EMA monographs recognize birch leaf preparations, though specific species documentation varies by regulatory region.

### Is Betula pubescens safe to use alongside immunosuppressive medications?

Betula pubescens extract has demonstrated immunomodulatory properties in preliminary research, which raises theoretical concerns about concurrent use with immunosuppressive drugs such as corticosteroids or biologics. Patients taking immunosuppressive medications should consult a healthcare provider before supplementing with Betula pubescens, as the herb may potentially interfere with therapeutic immune suppression. Current clinical evidence is insufficient to establish safety or contraindication at this time.

### What forms of Betula pubescens are most commonly used in clinical research studies?

Clinical and in vitro research on Betula pubescens has primarily utilized leaf extracts prepared through standardized extraction methods, often concentrated for bioactive compounds like betulinic acid and other triterpenes. Aqueous and ethanolic extracts are the most documented forms in peer-reviewed studies examining immunomodulatory and anti-cancer properties. The specific extraction method and standardization level significantly influence the bioactive compound profile and results observed in research.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*